Advertisement

Topics

Cardiovascular disease (CVD) Reports

13:13 EST 18th December 2018 | BioPortfolio

Vasospastic Angina Global Clinical Trials Review, H2, 2018 [Report Updated: 28092018] Prices from USD $2125

Vasospastic Angina Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Vasospastic Angina Global Clinical Trials Review, H2, 2018" provides an overview of Vasospastic Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Vasospastic Angina. Report includes an overview of trial numbers and their average enrollment in top...

Unstable Angina Global Clinical Trials Review, H2, 2018 [Report Updated: 28092018] Prices from USD $2125

Unstable Angina Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Unstable Angina Global Clinical Trials Review, H2, 2018" provides an overview of Unstable Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Unstable Angina. Report includes an overview of trial numbers and their average enrollment in top countries c...

KOL Perspectives: Cardiovascular safety profile of JAK inhibitors in Rheumatoid Arthritis [Report Updated: 01022018] Prices from USD $2125

KOL Perspectives: Cardiovascular safety profile of JAK inhibitors in Rheumatoid ArthritisSummaryThis KOL Insight briefing focuses on KOL opinions of the safety of JAK inhibitors in rheumatoid arthritis RA.The briefing includes analysis of KOL opinion on the following topic areas Baricitinib safety profile with regards to cardiovascular signal Tofacitinib safety profile with regards to cardiovasc...

Systolic Heart Failure Global Clinical Trials Review, H2, 2018 [Report Updated: 31082018] Prices from USD $2125

Systolic Heart Failure Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Systolic Heart Failure Global Clinical Trials Review, H2, 2018" provides an overview of Systolic Heart Failure clinical trials scenario. This report provides top line data relating to the clinical trials on Systolic Heart Failure. Report includes an overview of trial numbers and their average e...

Edwards Lifesciences Corp EW Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummaryEdwards Lifesciences Corp Edwards is a medical technology company, which focuses on the development, manufacture and marketing of products and technologies to treat structural heart disease, and help provide critical care and surgical monitoring. It develops and commercializes heart valve products such as heart valve systems and repair products aimed at the replacement or repair of a patien...

Hypertrophic Cardiomyopathy Pipeline Review, H2 2018 [Report Updated: 09102018] Prices from USD $2000

Hypertrophic Cardiomyopathy Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypertrophic Cardiomyopathy Pipeline Review, H2 2018, provides an overview of the Hypertrophic Cardiomyopathy Cardiovascular pipeline landscape.Hypertrophic cardiomyopathy HCM is a disease in which the heart muscle myocardium becomes abnormally thick hype...

Unstable Angina Global Clinical Trials Review, H2, 2018 [Report Updated: 28092018] Prices from USD $2500

Unstable Angina Global Clinical Trials Review, H2, 2018SummaryGlobalData's clinical trial report, Unstable Angina Global Clinical Trials Review, H2, 2018" provides an overview of Unstable Angina clinical trials scenario. This report provides top line data relating to the clinical trials on Unstable Angina. Report includes an overview of trial numbers and their average enrollment in top countries c...

Cytochrome P450 11B2 Mitochondrial Aldosterone Synthase or Cytochrome P450Aldo or Cytochrome P450C18 or Steroid 18 Hydroxylase or CYP11B2 or EC 1.14.15.4 or EC 1.14.15.5 Pipeline Review, H2 2018 [Report Updated: 16102018] Prices from USD $3500

Cytochrome P450 11B2 Mitochondrial Aldosterone Synthase or Cytochrome P450Aldo or Cytochrome P450C18 or Steroid 18 Hydroxylase or CYP11B2 or EC 1.14.15.4 or EC 1.14.15.5 Pipeline Review, H2 2018SummaryAccording to the recently published report 'Cytochrome P450 11B2 Mitochondrial Pipeline Review, H2 2018'; Cytochrome P450 11B2 Mitochondrial Aldosterone Synthase or Cytochrome P450Aldo or Cytochrom...

Myocarditis Pipeline Review, H2 2018 [Report Updated: 07082018] Prices from USD $2000

Myocarditis Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Myocarditis Pipeline Review, H2 2018, provides an overview of the Myocarditis Cardiovascular pipeline landscape.Myocarditis is inflammation of the heart muscle. Myocarditis is an uncommon disorder that is usually caused by viral, bacterial, or fungal infections that reac...

Syncardia Systems LLC Medical Equipment Deals and Alliances Profile [Report Updated: 16102018] Prices from USD $250

SummarySyncardia Systems LLC SynCardia, a subsidiary of Versa Capital Management, Inc. develops and manufactures artificial human heart. Its flagship product, SynCardia temporary Total Artificial Heart TAHt temporarily takes up the complete function of a failed human heart in patients suffering from final stage biventricular heart failure BHF before receiving a successful heart transplant. The TAH...

Atherosclerosis Pipeline Review, H2 2018 [Report Updated: 11092018] Prices from USD $2000

Atherosclerosis Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atherosclerosis Pipeline Review, H2 2018, provides an overview of the Atherosclerosis Cardiovascular pipeline landscape.Atherosclerosis or arteriosclerotic vascular disease is a condition where the arteries become narrowed and hardened due to an excessive build up of...

Angina Angina Pectoris Pipeline Review, H2 2018 [Report Updated: 11092018] Prices from USD $2000

Angina Angina Pectoris Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Angina Angina Pectoris Pipeline Review, H2 2018, provides an overview of the Angina Angina Pectoris Cardiovascular pipeline landscape.Angina pectoris is a term that describes chest pain caused by myocardial ischemia. It usually occurs on exertion and is reliev...

Atrial Fibrillation Pipeline Review, H2 2018 [Report Updated: 07082018] Prices from USD $2000

Atrial Fibrillation Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Atrial Fibrillation Pipeline Review, H2 2018, provides an overview of the Atrial Fibrillation Cardiovascular pipeline landscape.Atrial fibrillation is an irregular and often rapid heart rate that commonly causes poor blood flow to the body. Symptoms include decre...

Edwards Lifesciences Corp EW Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12102018] Prices from USD $250

SummaryEdwards Lifesciences Corp Edwards is a medical technology company, which focuses on the development, manufacture and marketing of products and technologies to treat structural heart disease, and help provide critical care and surgical monitoring. It develops and commercializes heart valve products such as heart valve systems and repair products aimed at the replacement or repair of a patien...

EU5 Cardiac Assist Procedures Outlook to 2025 [Report Updated: 02072018] Prices from USD $3995

EU5 Cardiac Assist Procedures Outlook to 2025SummaryGlobalData's new report, EU5 Cardiac Assist Procedures Outlook to 2025, provides key procedures data on the EU5 Cardiac Assist Procedures. The report provides procedure volumes within market segments Total Artificial Heart TAH Implant Procedures and Ventricular Assist Procedures.The data in the report is derived from dynamic market forecast mode...

Ventricular Tachycardia Pipeline Review, H2 2018 [Report Updated: 09102018] Prices from USD $2000

Ventricular Tachycardia Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Ventricular Tachycardia Pipeline Review, H2 2018, provides an overview of the Ventricular Tachycardia Cardiovascular pipeline landscape.Ventricular tachycardia is a very fast heart rhythm that begins in the ventricles. Symptoms of ventricular tachycardia incl...

Transmembrane Prolyl 4 Hydroxylase Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11. Pipeline Review, H2 2018 [Report Updated: 18092018] Prices from USD $3500

Transmembrane Prolyl 4 Hydroxylase Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11. Pipeline Review, H2 2018SummaryAccording to the recently published report 'Transmembrane Prolyl 4 Hydroxylase Pipeline Review, H2 2018'; Transmembrane Prolyl 4 Hydroxylase Hypoxia Inducible Factor Prolyl Hydroxylase 4 or P4HTM or EC 1.14.11. pipeline Target constitutes close to 9 molecules. T...

Germany Cardiovascular Procedures Outlook to 2025 Cardiac Assist Procedures, Cardiac Rhythm Management CRM Procedures, Cardiovascular Surgery Procedures, Clot Management Procedures and Others [Report Updated: 10072018] Prices from USD $3995

Germany Cardiovascular Procedures Outlook to 2025 Cardiac Assist Procedures, Cardiac Rhythm Management CRM Procedures, Cardiovascular Surgery Procedures, Clot Management Procedures and OthersSummaryGlobalData's new report, Germany Cardiovascular Procedures Outlook to 2025, provides key procedures data on the Germany Cardiovascular Procedures. The report provides procedure volumes within market ca...

National Heart Lung and Blood Institute Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27092018] Prices from USD $250

SummaryNational Heart Lung and Blood Institute NHLBI, a subsidiary of National Institutes of Health is a medical research institute that provides treatment for heart, lung, and blood diseases.The institute conducts research studies with patients who have diseases of heart and blood vessels, lungs, blood cells and bone marrow, and cholesterol. It develops health education and awareness programs to ...

Mexico Cardiovascular Procedures Outlook to 2025 Cardiac Assist Procedures, Cardiac Rhythm Management CRM Procedures, Cardiovascular Surgery Procedures, Clot Management Procedures and Others [Report Updated: 10072018] Prices from USD $3995

Mexico Cardiovascular Procedures Outlook to 2025 Cardiac Assist Procedures, Cardiac Rhythm Management CRM Procedures, Cardiovascular Surgery Procedures, Clot Management Procedures and OthersSummaryGlobalData's new report, Mexico Cardiovascular Procedures Outlook to 2025, provides key procedures data on the Mexico Cardiovascular Procedures. The report provides procedure volumes within market categ...

France Cardiovascular Procedures Outlook to 2025 Cardiac Assist Procedures, Cardiac Rhythm Management CRM Procedures, Cardiovascular Surgery Procedures, Clot Management Procedures and Others [Report Updated: 10072018] Prices from USD $3995

France Cardiovascular Procedures Outlook to 2025 Cardiac Assist Procedures, Cardiac Rhythm Management CRM Procedures, Cardiovascular Surgery Procedures, Clot Management Procedures and OthersSummaryGlobalData's new report, France Cardiovascular Procedures Outlook to 2025, provides key procedures data on the France Cardiovascular Procedures. The report provides procedure volumes within market categ...

DalCor Pharmaceuticals Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12092018] Prices from USD $250

SummaryDalCor Pharmaceuticals Inc DalCor Pharmaceuticals researches and develops precision medicine for patients suffering from cardiovascular diseases. The company is engaged in development of Dalcetrapib, a cholesterol ester transfer protein CETP inhibitor which is intended to reduce cardiovascular events in a genetically distinct subset of patients. DalCor Pharmaceuticals is also engaged in the...

Arrhythmias Pipeline Review, H2 2018 [Report Updated: 07082018] Prices from USD $2000

Arrhythmias Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Arrhythmias Pipeline Review, H2 2018, provides an overview of the Arrhythmias Cardiovascular pipeline landscape.An arrhythmia is a problem with the rate or rhythm of the heartbeat. During an arrhythmia, the heart can beat too fast, too slow, or with an irregular rhythm. ...

Arterial Thrombosis Pipeline Review, H2 2018 [Report Updated: 11092018] Prices from USD $2000

Arterial Thrombosis Pipeline Review, H2 2018SummaryGlobal Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Arterial Thrombosis Pipeline Review, H2 2018, provides an overview of the Arterial Thrombosis Cardiovascular pipeline landscape.Arterial thrombosis is a blood clot that develops in an artery. Symptoms include lack of pulse, pain or spasms in the muscles, pale ski...

United States Cardiovascular Procedures Outlook to 2025 Cardiac Assist Procedures, Cardiac Rhythm Management CRM Procedures, Cardiovascular Surgery Procedures, Clot Management Procedures and Others [Report Updated: 02072018] Prices from USD $3995

United States Cardiovascular Procedures Outlook to 2025 Cardiac Assist Procedures, Cardiac Rhythm Management CRM Procedures, Cardiovascular Surgery Procedures, Clot Management Procedures and OthersSummaryGlobalData's new report, United States Cardiovascular Procedures Outlook to 2025, provides key procedures data on the United States Cardiovascular Procedures. The report provides procedure volume...

Advertisement
Quick Search
Advertisement
Advertisement

 

review and buy Cardiovascular disease (CVD) market research data and corporate reports here